Evidence map›Paper›PMID 27043586›Full record

ArticleInternational journal of environmental research and public health2016

Association between Aflatoxin M₁ and Liver Disease in HBV/HCV Infected Persons in Ghana.

Clarrisa Afum, Lorene Cudjoe, Justin Hills, Raymond Hunt, Luz A Padilla, Sarah Elmore, Abena Afriyie, Ohene Opare-Sem, Timothy Phillips, Pauline E Jolly

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Lower Frequency ofGastro hep advances · 2025
    Article
  4. Review
  5. Article
  6. Optical and Electrochemical Aptasensors for Sensitive Detection of Aflatoxin BMethods in molecular biology (Clifton, N.J.) · 2022
    Article
  7. Article
  8. Toxicology reports · 2021
    Review
  9. Article
  10. Article
  11. Risk assessment of aflatoxins in food.EFSA journal. European Food Safety Authority · 2020
    Article
  12. Review
  13. Review
  14. Review
  15. Potential of AtoxigenicFrontiers in microbiology · 2019
    Article
  16. Article
  17. Article
  18. Determination of Aflatoxin MKorean journal for food science of animal resources · 2017
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Clarrisa AfumDepartment of Epidemiology, School of Public Health, Ryals Public Health Building, University of Alabama at Birmingham, 1665 University Boulevard Birmingham, Birmingham, AL 35294-002, USA. clarrisaafum@gmail.com.
Lorene CudjoeDepartment of Epidemiology, School of Public Health, Ryals Public Health Building, University of Alabama at Birmingham, 1665 University Boulevard Birmingham, Birmingham, AL 35294-002, USA. lorenecudjoe@gmail.com.
Justin HillsDepartment of Epidemiology, School of Public Health, Ryals Public Health Building, University of Alabama at Birmingham, 1665 University Boulevard Birmingham, Birmingham, AL 35294-002, USA. jlhills14@gmail.com.
Raymond HuntDepartment of Epidemiology, School of Public Health, Ryals Public Health Building, University of Alabama at Birmingham, 1665 University Boulevard Birmingham, Birmingham, AL 35294-002, USA. rbhunt@cchs.ua.edu.
Luz A PadillaDepartment of Epidemiology, School of Public Health, Ryals Public Health Building, University of Alabama at Birmingham, 1665 University Boulevard Birmingham, Birmingham, AL 35294-002, USA. apadilla@uab.edu.
Sarah ElmoreVeterinary Medicine & Biomedical Sciences, Texas A & M University, College Station, TX 77845, USA. SELmore@cvm.tamu.edu.
Abena AfriyieDepartment of Epidemiology, School of Public Health, Ryals Public Health Building, University of Alabama at Birmingham, 1665 University Boulevard Birmingham, Birmingham, AL 35294-002, USA. aafriyie09@gmail.com.
Ohene Opare-SemSchool of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. oparesem@hotmail.com.
Timothy PhillipsVeterinary Medicine & Biomedical Sciences, Texas A & M University, College Station, TX 77845, USA. tphillips@cvm.tamu.edu.
Pauline E JollyDepartment of Epidemiology, School of Public Health, Ryals Public Health Building, University of Alabama at Birmingham, 1665 University Boulevard Birmingham, Birmingham, AL 35294-002, USA. jollyp@uab.edu.
University of Alabama at Birmingham · USTexas A&M University · USKwame Nkrumah University of Science and Technology · GH

Funding

UAB CANCER RESEARCH EXPERIENCES FOR STUDENTS(CARES)R25CA076023 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SMITH, PETER R., WATERBOR, JOHN W · 1999 to 2020
$5.6M
UAB Public Health/Biomedical Research Training ProgramT37MD001448 · NIMHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JOLLY, PAULINE EVADNE · 2005 to 2024
$4.8M
NCI NIH HHS R25 CA076023NCI NIH HHS R25CA076023NIMHD NIH HHS 5 T37 MD 001448NIMHD NIH HHS T37 MD001448
6 · The paper itself

Abstract

Aflatoxins are produced by the fungi Aspergillus flavus and Aspergillus parasiticus and are common food contaminants in tropical developing countries. Extensive aflatoxin consumption has been shown to be highly associated with liver disease. A case-control study was conducted to determine the association between aflatoxin and liver disease in Kumasi, Ghana. A questionnaire was administered to examine socio-demographic characteristics and food storage and consumption practices, and urine samples were collected to measure levels of the aflatoxin metabolite (AFM₁). Two hundred and seventy-six people participated in the study; 38 had liver disease (cases), 136 had neither hepatitis B/C nor liver disease (negative controls), and 102 were hepatitis B/C positive without liver cancer (positive controls). A much higher percent of participants in each group was male (76% of cases, 88% of negative controls and 65% of positive controls). Multivariate analysis showed that age was a significant predictor for being a case when cases were compared to negative controls. The odds of being a case was 70% less for participants aged 25-34 years (odds ratios (OR) 0.30; 95% confidence interval (CI) 0.10-0.88) compared to those ≥45 years. For cases; Akans were seven times more likely to have AFM₁ levels below the median when compared to other ethnic groups (OR 7; CI 1.41-34.68). When cases were compared to positive controls, they were 2.29 times more likely to report awareness of aflatoxin contamination of groundnuts (95% CI 1.06-4.91). Cases were also two times more likely to report awareness of aflatoxin contamination of maize than all controls combined (95% CI 1.02-4.11). However, most cases reported that aflatoxin contamination does not cause sickness in humans. This shows that there is awareness of aflatoxin contamination without proper understanding of the serious potential adverse health impacts among these study participants. These findings indicate that educational interventions that stress the harmful health effects of aflatoxin in food, with an emphasis on the higher risk for males, are urgently needed. The reasons for lower aflatoxin levels among Akans need to be determined, and the findings used to design interventions that benefit other ethnic groups in the society.

Indexed as

AdultAflatoxin M1ArachisCase-Control StudiesFemaleFood ContaminationGhanaHepacivirusHepatitis B virusHumansLiver DiseasesMaleMiddle AgedMultivariate AnalysisOdds RatioYoung AdultAflatoxin M1aflatoxin M1Ghanahepatitis B/C virushepatocellular carcinomaliver disease

Identifiers

PMID27043586
PMCPMC4847039
OpenAlexW2319315524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.